CN105462909B - 一种高效表达人促卵泡激素的cho细胞的培养方法 - Google Patents
一种高效表达人促卵泡激素的cho细胞的培养方法 Download PDFInfo
- Publication number
- CN105462909B CN105462909B CN201511030146.1A CN201511030146A CN105462909B CN 105462909 B CN105462909 B CN 105462909B CN 201511030146 A CN201511030146 A CN 201511030146A CN 105462909 B CN105462909 B CN 105462909B
- Authority
- CN
- China
- Prior art keywords
- culture
- cell
- medium
- serum
- stimulating hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- 229940088597 hormone Drugs 0.000 title claims abstract description 27
- 239000005556 hormone Substances 0.000 title claims abstract description 27
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 title claims abstract description 11
- 241000699802 Cricetulus griseus Species 0.000 title claims abstract description 11
- 210000001672 ovary Anatomy 0.000 title claims abstract description 11
- 239000001963 growth medium Substances 0.000 claims abstract description 37
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 23
- 239000007640 basal medium Substances 0.000 claims abstract description 22
- 239000008103 glucose Substances 0.000 claims abstract description 19
- 230000003833 cell viability Effects 0.000 claims abstract description 16
- 238000011534 incubation Methods 0.000 claims abstract description 14
- 239000006285 cell suspension Substances 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 230000010261 cell growth Effects 0.000 claims abstract description 6
- 230000001502 supplementing effect Effects 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 45
- 239000002609 medium Substances 0.000 claims description 21
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 18
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 18
- 229930182817 methionine Natural products 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 18
- 238000003306 harvesting Methods 0.000 claims description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 9
- 238000011081 inoculation Methods 0.000 claims description 8
- 230000003204 osmotic effect Effects 0.000 claims description 7
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims description 6
- 229940062044 oxygen 40 % Drugs 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 2
- 238000005138 cryopreservation Methods 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims 1
- 230000004899 motility Effects 0.000 abstract description 11
- 239000013589 supplement Substances 0.000 abstract description 10
- 239000000725 suspension Substances 0.000 abstract description 10
- 230000003321 amplification Effects 0.000 abstract description 9
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 9
- 210000002966 serum Anatomy 0.000 abstract description 9
- 238000004113 cell culture Methods 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 6
- 238000000855 fermentation Methods 0.000 abstract description 5
- 230000004151 fermentation Effects 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 4
- 238000004114 suspension culture Methods 0.000 abstract description 3
- 229960000074 biopharmaceutical Drugs 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 12
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 12
- 229940028334 follicle stimulating hormone Drugs 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- 239000012930 cell culture fluid Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 108010082302 Human Follicle Stimulating Hormone Proteins 0.000 description 4
- 102000003864 Human Follicle Stimulating Hormone Human genes 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 102000002287 alpha Subunit Glycoprotein Hormones Human genes 0.000 description 1
- 108010000732 alpha Subunit Glycoprotein Hormones Proteins 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 108010006578 follitropin alfa Proteins 0.000 description 1
- 108010081934 follitropin beta Proteins 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 229940057854 gonal f Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 229940071229 oxygen 45 % Drugs 0.000 description 1
- 229940062042 oxygen 50 % Drugs 0.000 description 1
- 229940103067 oxygen 60 % Drugs 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511030146.1A CN105462909B (zh) | 2015-12-31 | 2015-12-31 | 一种高效表达人促卵泡激素的cho细胞的培养方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511030146.1A CN105462909B (zh) | 2015-12-31 | 2015-12-31 | 一种高效表达人促卵泡激素的cho细胞的培养方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105462909A CN105462909A (zh) | 2016-04-06 |
CN105462909B true CN105462909B (zh) | 2019-09-27 |
Family
ID=55601071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511030146.1A Active CN105462909B (zh) | 2015-12-31 | 2015-12-31 | 一种高效表达人促卵泡激素的cho细胞的培养方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105462909B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107760650B (zh) * | 2016-08-22 | 2020-07-24 | 厦门大学 | 一种改造的cho细胞及其用途 |
CN107760651A (zh) * | 2016-08-23 | 2018-03-06 | 四川科伦博泰生物医药股份有限公司 | 一种细胞培养基及生产蛋白质的方法 |
CN108251375B (zh) * | 2016-12-28 | 2021-05-07 | 康立泰药业有限公司 | 一种发酵生产重组人白介素-12的方法 |
CN109385401A (zh) * | 2017-08-10 | 2019-02-26 | 北京泰德制药股份有限公司 | 一种表达重组蛋白的cho细胞的培养方法 |
CN109055426B (zh) * | 2018-08-06 | 2021-06-25 | 智享生物(苏州)有限公司 | 一种在中华仓鼠卵巢细胞中表达生产类人润滑素的方法 |
CN108949870B (zh) * | 2018-08-06 | 2021-05-28 | 智享生物(苏州)有限公司 | 一种生产重组血小板源生长因子的方法 |
CN110042137B (zh) * | 2019-05-14 | 2023-02-28 | 上海赛迈生物科技有限公司 | 高密度灌注培养重组cho细胞生产人促卵泡激素的方法、培养基及其应用 |
CN110305903B (zh) * | 2019-07-31 | 2021-10-01 | 江苏璟泽生物医药有限公司 | 重组人促卵泡激素及其制备方法 |
CN113355286A (zh) * | 2020-03-02 | 2021-09-07 | 成都彤琦恩生物科技有限公司 | 一种高效表达重组猫干扰素ω2的哺乳动物细胞培养工艺 |
CN113462648A (zh) * | 2020-03-31 | 2021-10-01 | 成都彤琦恩生物科技有限公司 | 一种高效表达重组猫干扰素ω2突变体的哺乳动物细胞培养工艺 |
CN111560399B (zh) * | 2020-05-22 | 2021-07-06 | 苏州君盟生物医药科技有限公司 | 细胞大规模瞬时转染方法 |
CN112391350A (zh) * | 2020-10-30 | 2021-02-23 | 北京双鹭药业股份有限公司 | 高效表达抗egfr单克隆抗体细胞的筛选培养方法 |
CN112679601A (zh) * | 2021-01-20 | 2021-04-20 | 长春生物制品研究所有限责任公司 | 一种高比活性重组人促卵泡激素的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101258236A (zh) * | 2005-07-05 | 2008-09-03 | 阿雷斯贸易股份有限公司 | 用于生产重组促性腺激素的无血清培养基 |
CN101597633A (zh) * | 2008-06-03 | 2009-12-09 | 哈药集团生物工程有限公司 | 一种新的细胞悬浮培养生产重组人促红细胞生成素的方法 |
CN101720332A (zh) * | 2007-06-28 | 2010-06-02 | 拜奥吉耐里克斯股份公司 | 生产促卵泡激素的细胞克隆 |
CN102443565A (zh) * | 2010-09-30 | 2012-05-09 | 成都康弘生物科技有限公司 | 一种适于培养cho细胞的培养基及其培养工艺 |
CN104894055A (zh) * | 2015-06-15 | 2015-09-09 | 成都金凯生物技术有限公司 | 一种优化的细胞培养基、细胞培养方法及其在制备蛋白和抗体中的应用 |
-
2015
- 2015-12-31 CN CN201511030146.1A patent/CN105462909B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101258236A (zh) * | 2005-07-05 | 2008-09-03 | 阿雷斯贸易股份有限公司 | 用于生产重组促性腺激素的无血清培养基 |
CN101720332A (zh) * | 2007-06-28 | 2010-06-02 | 拜奥吉耐里克斯股份公司 | 生产促卵泡激素的细胞克隆 |
CN101597633A (zh) * | 2008-06-03 | 2009-12-09 | 哈药集团生物工程有限公司 | 一种新的细胞悬浮培养生产重组人促红细胞生成素的方法 |
CN102443565A (zh) * | 2010-09-30 | 2012-05-09 | 成都康弘生物科技有限公司 | 一种适于培养cho细胞的培养基及其培养工艺 |
CN104894055A (zh) * | 2015-06-15 | 2015-09-09 | 成都金凯生物技术有限公司 | 一种优化的细胞培养基、细胞培养方法及其在制备蛋白和抗体中的应用 |
Non-Patent Citations (3)
Title |
---|
CHO细胞表达rhGFH的大规模无血清培养工艺的研究;石欣欣;《中国优秀硕士学位论文全文数据库 医药卫生科技辑 E059-8》;20150515(第5期);参见摘要,第12页第2段-第3段,第13页第2.1.2节,第14页2.1.3节,第15页2.2.2节,第17-18页第2.2.10节和2.2.11节,第18页第2.2.13节,19页2.2.15-2.2.16节;第27页第1段,第33页3.2.3节,第39-40页第3.4.1节和3.4.2节,第41页3.4.4.节,第44页第3.5.2节及图3.33,第48页第1-5段 * |
Highly expressed recombinant human follicle-stimulating hormone from Chinese hamster ovary cells grown in serum-free medium and its effect on induction of folliculogenesis and ovulation;Dong-Jae Kim et al;《Fertility and Sterility》;20100315;第93卷(第8期);2652-2660 * |
Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin;Baik JY et al;《Biotechnology Journal》;20150624;第10卷(第7期);1067-1081 * |
Also Published As
Publication number | Publication date |
---|---|
CN105462909A (zh) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105462909B (zh) | 一种高效表达人促卵泡激素的cho细胞的培养方法 | |
Elias et al. | Enhanced growth of sf‐9 cells to a maximum density of 5.2× 107 cells per mL and production of β‐galactosidase at high cell density by fed batch culture | |
Chuppa et al. | Fermentor temperature as a tool for control of high‐density perfusion cultures of mammalian cells | |
CN102057053A (zh) | 用于促红细胞生成素发酵生产的方法 | |
CN107937360A (zh) | 一种葡萄糖氧化酶在毕赤酵母中的高密度发酵方法 | |
CN102382794B (zh) | 一种哺乳动物细胞的灌流培养方法 | |
CN111454877B (zh) | 一种cho细胞培养方法 | |
CN102154189A (zh) | 一种rhG-CSF重组工程菌的发酵培养方法 | |
CN107142249A (zh) | 一种全悬浮细胞培养生产猪伪狂犬病毒抗原的方法 | |
CN107190034A (zh) | 生产蛋白质的方法 | |
CN108866013A (zh) | 一种大规模生产慢病毒的方法 | |
CN116376792A (zh) | 酪氨酸生产菌株的定向改造方法及生产菌株与酪氨酸发酵方法 | |
CN109628407A (zh) | 高密度长期培养表达抗vegf人源化单克隆抗体重组cho细胞的方法 | |
CN110656148A (zh) | 一种静息细胞转化植物甾醇制备去氢表雄酮的方法 | |
CN102994547B (zh) | 重组人促红素-ctp融合蛋白生产工艺及应用 | |
CN105316371B (zh) | 一种用于提高色氨酸发酵产量的方法 | |
CN101892286B (zh) | 黑素细胞生物活性检测及个体化培养方法 | |
CN103255238A (zh) | 一种控制哺乳动物细胞乳酸生成的方法 | |
CN101245342A (zh) | 一步法制备基因重组人源铜、锌超氧化歧化酶工艺 | |
CN105838664B (zh) | 一种细胞悬浮培养生产重组人血小板生成素的方法 | |
CN102776260A (zh) | 一种高效表达重组人凝血八因子的方法 | |
CN103589769B (zh) | 一种重组猪干扰素α1基因工程菌的高密度发酵方法 | |
CN112679601A (zh) | 一种高比活性重组人促卵泡激素的制备方法 | |
CN108913739A (zh) | 一种基于pH值控制的脱氮假单胞杆菌生产维生素B12的方法 | |
CN104130971B (zh) | 一种重组人促红素的无血清培养基,其应用以及重组人促红素的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Guojun Inventor after: Jiang Yuanyuan Inventor after: Liu Shanshan Inventor after: Zhang Yiwen Inventor after: Liu Yuting Inventor after: Ge Jingcheng Inventor after: Huang Yan Inventor after: Ding Hui Inventor after: Liu Jiaji Inventor after: Zhang Xinyan Inventor after: Yuan Shujie Inventor after: Yang Xinchun Inventor after: Li Zhengwu Inventor after: Wang Rui Inventor after: Guan Lufan Inventor after: Gao Jing Inventor after: Zhao Huanan Inventor after: Yuan Yuan Inventor after: Zhang Daoxu Inventor after: Zhang Xueting Inventor after: Lv Zhonghua Inventor after: Wang Ying Inventor after: Meng Qingyong Inventor after: Zhang Lei Inventor after: Gao Hongmei Inventor before: Yuan Shujie Inventor before: Guan Lufan Inventor before: Jiang Yuanyuan Inventor before: Lv Zhonghua Inventor before: Gao Hongmei Inventor before: Gao Jing Inventor before: Zhao Huanan Inventor before: Li Zhengwu Inventor before: Li Guojun Inventor before: Wang Ying Inventor before: Yuan Yuan Inventor before: Zhang Xueting Inventor before: Wang Rui Inventor before: Meng Qingyong Inventor before: Zhang Lei |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CI03 | Correction of invention patent |
Correction item: Inventor Correct: Li Guo Jun|Yang Xin Chun|Zhang Dao Xu|Zhang Xue Ting|Lv Zhong Hua|Wang Ying|Meng Qing Yong|Zhang Lei|Gao Hong Mei|Jiang Yuan Yuan|Liu Pan Pan|Zhang Yi Wen|Liu Yu Ting|Ge Jing Cheng|Huang Yan|Ding Hui|Liu Jia Ji|Zhang Xin Yan|Yuan Shu Jie|Li Zheng Wu|Wang Rui|Guan Lu Fan|Gao Jing|Zhao Hua Nan|Yuan Yuan False: Li Guo Jun|Yang Xin Chun|Zhang Dao Xu|Zhang Xue Ting|Lv Zhong Hua|Wang Ying|Meng Qing Yong|Zhang Lei|Gao Hong Mei|Jiang Yuan Yuan|Liu Shan Shan|Zhang Yi Wen|Liu Yu Ting|Ge Jing Cheng|Huang Yan|Ding Hui|Liu Jia Ji|Zhang Xin Yan|Yuan Shu Jie|Li Zheng Wu|Wang Rui|Guan Lu Fan|Gao Jing|Zhao Hua Nan|Yuan Yuan Number: 21-02 Volume: 35 |
|
CI03 | Correction of invention patent | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221026 Address after: No. 68, Limin West 4th Street, Limin Development Zone, Harbin, Heilongjiang 150500 Patentee after: HARBIN PHARMACEUTICAL GROUP HOLDING Co.,Ltd. Patentee after: HARBIN PHARMACEUTICAL Group TECHNOLOGY CENTER Address before: 150025 Xi'an Street, Limin Development Zone, Harbin, Heilongjiang Patentee before: HARBIN PHARMACEUTICAL Group TECHNOLOGY CENTER |
|
TR01 | Transfer of patent right |